Page last updated: 2024-10-30

letrozole and Klinefelter Syndrome

letrozole has been researched along with Klinefelter Syndrome in 1 studies

Klinefelter Syndrome: A form of male HYPOGONADISM, characterized by the presence of an extra X CHROMOSOME, small TESTES, seminiferous tubule dysgenesis, elevated levels of GONADOTROPINS, low serum TESTOSTERONE, underdeveloped secondary sex characteristics, and male infertility (INFERTILITY, MALE). Patients tend to have long legs and a slim, tall stature. GYNECOMASTIA is present in many of the patients. The classic form has the karyotype 47,XXY. Several karyotype variants include 48,XXYY; 48,XXXY; 49,XXXXY, and mosaic patterns ( 46,XY/47,XXY; 47,XXY/48,XXXY, etc.).

Research Excerpts

ExcerptRelevanceReference
" ISS boys with letrozole-induced hypergonadotropic hyperandrogenism had, after 12 months of therapy, higher INSL3 levels than did placebo treated (0."5.12Serum insulin-like factor 3 levels during puberty in healthy boys and boys with Klinefelter syndrome. ( Andersson, AM; Bay, K; Dunkel, L; Hero, M; Wikström, AM, 2006)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Wikström, AM1
Bay, K1
Hero, M1
Andersson, AM1
Dunkel, L1

Trials

1 trial available for letrozole and Klinefelter Syndrome

ArticleYear
Serum insulin-like factor 3 levels during puberty in healthy boys and boys with Klinefelter syndrome.
    The Journal of clinical endocrinology and metabolism, 2006, Volume: 91, Issue:11

    Topics: Adolescent; Age Determination by Skeleton; Aromatase Inhibitors; Body Height; Child; Dwarfism; Healt

2006